Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Thermal decomposition of chemotherapeutic preparations and expectorants.

Talanta

Radecki A, Wesołowski M.
PMID: 18962715
Talanta. 1980 Jun;27(6):507-12. doi: 10.1016/0039-9140(80)80072-5.

The thermal decomposition of 31 drugs containing sulphonamides, antituberculous agents, dyes, an oxidant, carboxylic acid derivatives and formaldehyde, expectorants and codeine phosphate has been studied by differential thermal analysis (DTA) and thermogravimetry (TG). The DTA, TG and differential TG...

Cite
Radecki A, Wesołowski M. Thermal decomposition of chemotherapeutic preparations and expectorants. Talanta. 1980;27(6):507-12doi: 10.1016/0039-9140(80)80072-5.
Radecki, A., & Wesołowski, M. (1980). Thermal decomposition of chemotherapeutic preparations and expectorants. Talanta, 27(6), 507-12. https://doi.org/10.1016/0039-9140(80)80072-5
Radecki, A, and Wesołowski, M. "Thermal decomposition of chemotherapeutic preparations and expectorants." Talanta vol. 27,6 (1980): 507-12. doi: https://doi.org/10.1016/0039-9140(80)80072-5
Radecki A, Wesołowski M. Thermal decomposition of chemotherapeutic preparations and expectorants. Talanta. 1980 Jun;27(6):507-12. doi: 10.1016/0039-9140(80)80072-5. PMID: 18962715.
Copy Download .nbib Format: NLM
Pattern of drug utilization in acute tonsillitis in a teaching hospital in Nepal.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Rehan HS.
PMID: 23119972
Indian J Otolaryngol Head Neck Surg. 2003 Jul;55(3):176-9. doi: 10.1007/BF02991947.

OBJECTIVE: A prospective study was undertaken to find out the baseline data on prescribing patten of drugs in acute tonsillitis.METHODS: Prescriptions far acute tonsillitis were collected outside the ENT-OPD over a period of 6 months and were analyzed.RESULTS: The...

Cite
Rehan HS. Pattern of drug utilization in acute tonsillitis in a teaching hospital in Nepal. Indian J Otolaryngol Head Neck Surg. 2003;55(3):176-9doi: 10.1007/BF02991947.
Rehan, H. S. (2003). Pattern of drug utilization in acute tonsillitis in a teaching hospital in Nepal. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 55(3), 176-9. https://doi.org/10.1007/BF02991947
Rehan, H S. "Pattern of drug utilization in acute tonsillitis in a teaching hospital in Nepal." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 55,3 (2003): 176-9. doi: https://doi.org/10.1007/BF02991947
Rehan HS. Pattern of drug utilization in acute tonsillitis in a teaching hospital in Nepal. Indian J Otolaryngol Head Neck Surg. 2003 Jul;55(3):176-9. doi: 10.1007/BF02991947. PMID: 23119972; PMCID: PMC3451129.
Copy Download .nbib Format: NLM
On the Action of Apomorphine and Apocodeine, with Reference to their Value as Expectorants in the Treatment of Chronic Bronchitis.

British medical journal

Murrell W.
PMID: 20753261
Br Med J. 1891 Feb 28;1(1574):452-6. doi: 10.1136/bmj.1.1574.452.

No abstract available.

Cite
Murrell W. On the Action of Apomorphine and Apocodeine, with Reference to their Value as Expectorants in the Treatment of Chronic Bronchitis. Br Med J. 1891;1(1574):452-6doi: 10.1136/bmj.1.1574.452.
Murrell, W. (1891). On the Action of Apomorphine and Apocodeine, with Reference to their Value as Expectorants in the Treatment of Chronic Bronchitis. British medical journal, 1(1574), 452-6. https://doi.org/10.1136/bmj.1.1574.452
Murrell, W. "On the Action of Apomorphine and Apocodeine, with Reference to their Value as Expectorants in the Treatment of Chronic Bronchitis." British medical journal vol. 1,1574 (1891): 452-6. doi: https://doi.org/10.1136/bmj.1.1574.452
Murrell W. On the Action of Apomorphine and Apocodeine, with Reference to their Value as Expectorants in the Treatment of Chronic Bronchitis. Br Med J. 1891 Feb 28;1(1574):452-6. doi: 10.1136/bmj.1.1574.452. PMID: 20753261; PMCID: PMC2272794.
Copy Download .nbib Format: NLM
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?.

Clinical medicine insights. Ear, nose and throat

Scaglione F, Petrini O.
PMID: 30670922
Clin Med Insights Ear Nose Throat. 2019 Jan 09;12:1179550618821930. doi: 10.1177/1179550618821930. eCollection 2019.

BACKGROUND: Upper and lower respiratory tract infections are common conditions for which medical advice is sought, and their management relies on the use of prescription and over-the-counter (OTC) medicines. Ambroxol, bromhexine, carbocysteine, erdosteine, OBJECTIVE: To briefly review the evidence-based...

Cite
Scaglione F, Petrini O. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clin Med Insights Ear Nose Throat. 2019;12:1179550618821930doi: 10.1177/1179550618821930.
Scaglione, F., & Petrini, O. (2019). Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clinical medicine insights. Ear, nose and throat, 121179550618821930. https://doi.org/10.1177/1179550618821930
Scaglione, Francesco, and Petrini, Orlando. "Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?." Clinical medicine insights. Ear, nose and throat vol. 12 (2019): 1179550618821930. doi: https://doi.org/10.1177/1179550618821930
Scaglione F, Petrini O. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clin Med Insights Ear Nose Throat. 2019 Jan 09;12:1179550618821930. doi: 10.1177/1179550618821930. eCollection 2019. PMID: 30670922; PMCID: PMC6328955.
Copy Download .nbib Format: NLM
On the Efficacy of Small Doses of Morphia (as Opposed to the Use of Expectorants), in the Treatment of Hooping-Cough, Chronic Bronchitis, and Phthisis.

Edinburgh medical journal

Smith E.
PMID: 29647309
Edinb Med J. 1856 May;1(11):1001-1010.

No abstract available.

Cite
Smith E. On the Efficacy of Small Doses of Morphia (as Opposed to the Use of Expectorants), in the Treatment of Hooping-Cough, Chronic Bronchitis, and Phthisis. Edinb Med J. 1856;1(11):1001-1010
Smith, E. (1856). On the Efficacy of Small Doses of Morphia (as Opposed to the Use of Expectorants), in the Treatment of Hooping-Cough, Chronic Bronchitis, and Phthisis. Edinburgh medical journal, 1(11), 1001-1010.
Smith, Edward. "On the Efficacy of Small Doses of Morphia (as Opposed to the Use of Expectorants), in the Treatment of Hooping-Cough, Chronic Bronchitis, and Phthisis." Edinburgh medical journal vol. 1,11 (1856): 1001-1010.
Smith E. On the Efficacy of Small Doses of Morphia (as Opposed to the Use of Expectorants), in the Treatment of Hooping-Cough, Chronic Bronchitis, and Phthisis. Edinb Med J. 1856 May;1(11):1001-1010. PMID: 29647309; PMCID: PMC5307500.
Copy Download .nbib Format: NLM
Cough and cold medicine prescription rates can be significantly reduced by active intervention.

European journal of pediatrics

Csonka P, Heikkilä P, Koskela S, Palmu S, Lajunen N, Riihijärvi S, Huhtala H, Korppi M.
PMID: 34913111
Eur J Pediatr. 2021 Dec 15; doi: 10.1007/s00431-021-04344-0. Epub 2021 Dec 15.

Our aim was to construct and test an intervention programme to eradicate cough and cold medicine (CCM) prescriptions for children treated in a nationwide healthcare service company. The study was carried out in the largest private healthcare service company...

Cite
Csonka P, Heikkilä P, Koskela S, et al. Cough and cold medicine prescription rates can be significantly reduced by active intervention. Eur J Pediatr. 2021;doi: 10.1007/s00431-021-04344-0.
Csonka, P., Heikkilä, P., Koskela, S., Palmu, S., Lajunen, N., Riihijärvi, S., Huhtala, H., & Korppi, M. (2021). Cough and cold medicine prescription rates can be significantly reduced by active intervention. European journal of pediatrics, . https://doi.org/10.1007/s00431-021-04344-0
Csonka, Péter, et al. "Cough and cold medicine prescription rates can be significantly reduced by active intervention." European journal of pediatrics vol. (2021). doi: https://doi.org/10.1007/s00431-021-04344-0
Csonka P, Heikkilä P, Koskela S, Palmu S, Lajunen N, Riihijärvi S, Huhtala H, Korppi M. Cough and cold medicine prescription rates can be significantly reduced by active intervention. Eur J Pediatr. 2021 Dec 15; doi: 10.1007/s00431-021-04344-0. Epub 2021 Dec 15. PMID: 34913111; PMCID: PMC8673918.
Copy Download .nbib Format: NLM
The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.

Chronic obstructive pulmonary diseases (Miami, Fla.)

Ohar JA, Donohue JF, Spangenthal S.
PMID: 31647856
Chronic Obstr Pulm Dis. 2019 Oct 23;6(4). doi: 10.15326/jcopdf.6.4.2019.0139.

UNLABELLED: Chronic obstructive pulmonary disease is the third leading cause of death and disease burden worldwide. It includes a spectrum of diseases including chronic bronchitis which is characterized by overproduction, hypersecretion and decreased elimination of mucus. Chronic bronchitis has...

Cite
Ohar JA, Donohue JF, Spangenthal S. The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review. Chronic Obstr Pulm Dis. 2019;6(4)doi: 10.15326/jcopdf.6.4.2019.0139.
Ohar, J. A., Donohue, J. F., & Spangenthal, S. (2019). The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review. Chronic obstructive pulmonary diseases (Miami, Fla.), 6(4), . https://doi.org/10.15326/jcopdf.6.4.2019.0139
Ohar, Jill A, et al. "The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review." Chronic obstructive pulmonary diseases (Miami, Fla.) vol. 6,4 (2019). doi: https://doi.org/10.15326/jcopdf.6.4.2019.0139
Ohar JA, Donohue JF, Spangenthal S. The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review. Chronic Obstr Pulm Dis. 2019 Oct 23;6(4). doi: 10.15326/jcopdf.6.4.2019.0139. PMID: 31647856; PMCID: PMC7006698.
Copy Download .nbib Format: NLM
Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review).

Experimental and therapeutic medicine

Zhang T, Zhou X.
PMID: 24660026
Exp Ther Med. 2014 Apr;7(4):763-767. doi: 10.3892/etm.2014.1494. Epub 2014 Jan 21.

Airway mucus hypersecretion is a significant clinical and pathological feature of chronic inflammatory airway diseases. Its clinical presentations include recurrent coughing and phlegm. Airway mucus is closely associated with the occurrence, development and prognosis of chronic inflammatory airway diseases...

Cite
Zhang T, Zhou X. Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review). Exp Ther Med. 2014;7(4):763-767doi: 10.3892/etm.2014.1494.
Zhang, T., & Zhou, X. (2014). Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review). Experimental and therapeutic medicine, 7(4), 763-767. https://doi.org/10.3892/etm.2014.1494
Zhang, Ting, and Zhou, Xiangdong. "Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review)." Experimental and therapeutic medicine vol. 7,4 (2014): 763-767. doi: https://doi.org/10.3892/etm.2014.1494
Zhang T, Zhou X. Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review). Exp Ther Med. 2014 Apr;7(4):763-767. doi: 10.3892/etm.2014.1494. Epub 2014 Jan 21. PMID: 24660026; PMCID: PMC3961124.
Copy Download .nbib Format: NLM
A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter].

Journal of inflammation research

Kurukulaaratchy RJ, Rupani H, Fong WCG, Kyyaly A.
PMID: 34675596
J Inflamm Res. 2021 Oct 08;14:5183-5185. doi: 10.2147/JIR.S341547. eCollection 2021.

No abstract available.

Cite
Kurukulaaratchy RJ, Rupani H, Fong WCG, et al. A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]. J Inflamm Res. 2021;14:5183-5185doi: 10.2147/JIR.S341547.
Kurukulaaratchy, R. J., Rupani, H., Fong, W. C. G., & Kyyaly, A. (2021). A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]. Journal of inflammation research, 145183-5185. https://doi.org/10.2147/JIR.S341547
Kurukulaaratchy, Ramesh J, et al. "A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]." Journal of inflammation research vol. 14 (2021): 5183-5185. doi: https://doi.org/10.2147/JIR.S341547
Kurukulaaratchy RJ, Rupani H, Fong WCG, Kyyaly A. A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]. J Inflamm Res. 2021 Oct 08;14:5183-5185. doi: 10.2147/JIR.S341547. eCollection 2021. PMID: 34675596; PMCID: PMC8517631.
Copy Download .nbib Format: NLM
The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial.

Journal of thoracic disease

Ra SW, Kim SY, Lim YY, Park SJ, Rhee CK, Kim DK, Park YB, Lee CY, Yoon HK, Park JW, Yoo KH.
PMID: 33569179
J Thorac Dis. 2021 Jan;13(1):1-9. doi: 10.21037/jtd-20-1567.

BACKGROUND: Acute upper respiratory tract infection (AURI) together with acute bronchitis is the most common illness worldwide. Botanical medicines used as expectorants and antitussives have proven to be effective while also having excellent safety margins. We aimed at evaluating...

Cite
Ra SW, Kim SY, Lim YY, et al. The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial. J Thorac Dis. 2021;13(1):1-9doi: 10.21037/jtd-20-1567.
Ra, S. W., Kim, S. Y., Lim, Y. Y., Park, S. J., Rhee, C. K., Kim, D. K., Park, Y. B., Lee, C. Y., Yoon, H. K., Park, J. W., & Yoo, K. H. (2021). The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial. Journal of thoracic disease, 13(1), 1-9. https://doi.org/10.21037/jtd-20-1567
Ra, Seung Won, et al. "The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial." Journal of thoracic disease vol. 13,1 (2021): 1-9. doi: https://doi.org/10.21037/jtd-20-1567
Ra SW, Kim SY, Lim YY, Park SJ, Rhee CK, Kim DK, Park YB, Lee CY, Yoon HK, Park JW, Yoo KH. The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial. J Thorac Dis. 2021 Jan;13(1):1-9. doi: 10.21037/jtd-20-1567. PMID: 33569179; PMCID: PMC7867795.
Copy Download .nbib Format: NLM
Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.

Journal of psychopharmacology (Oxford, England)

Chiappini S, Schifano F, Corkery JM, Guirguis A.
PMID: 33427017
J Psychopharmacol. 2021 Jun;35(6):681-692. doi: 10.1177/0269881120959615. Epub 2021 Jan 10.

BACKGROUND: Promethazine is a medicinal product, available on its own or in combination with other ingredients including dextromethorphan, paracetamol and/or expectorants. Anecdotal reports have however indicated that promethazine may have a misuse potential, especially in adolescents.OBJECTIVE: We here aimed...

Cite
Chiappini S, Schifano F, Corkery JM, et al. Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. J Psychopharmacol. 2021;35(6):681-692doi: 10.1177/0269881120959615.
Chiappini, S., Schifano, F., Corkery, J. M., & Guirguis, A. (2021). Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. Journal of psychopharmacology (Oxford, England), 35(6), 681-692. https://doi.org/10.1177/0269881120959615
Chiappini, Stefania, et al. "Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports." Journal of psychopharmacology (Oxford, England) vol. 35,6 (2021): 681-692. doi: https://doi.org/10.1177/0269881120959615
Chiappini S, Schifano F, Corkery JM, Guirguis A. Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. J Psychopharmacol. 2021 Jun;35(6):681-692. doi: 10.1177/0269881120959615. Epub 2021 Jan 10. PMID: 33427017; PMCID: PMC8278560.
Copy Download .nbib Format: NLM
Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease.

Journal of translational internal medicine

Tian PW, Wen FQ.
PMID: 27847895
J Transl Int Med. 2015 Jun-Sep;3(3):89-92. doi: 10.1515/jtim-2015-0013. Epub 2015 Sep 30.

Airway mucus hypersecretion is one of the most important features of chronic obstructive pulmonary disease (COPD). Airway mucus hypersecretion in COPD patients results in outcomes such as rapid decline of lung function, poor quality of life, and high rate...

Cite
Tian PW, Wen FQ. Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease. J Transl Int Med. 2015;3(3):89-92doi: 10.1515/jtim-2015-0013.
Tian, P. W., & Wen, F. Q. (2015). Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease. Journal of translational internal medicine, 3(3), 89-92. https://doi.org/10.1515/jtim-2015-0013
Tian, Pan-Wen, and Wen, Fu-Qiang. "Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease." Journal of translational internal medicine vol. 3,3 (2015): 89-92. doi: https://doi.org/10.1515/jtim-2015-0013
Tian PW, Wen FQ. Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease. J Transl Int Med. 2015 Jun-Sep;3(3):89-92. doi: 10.1515/jtim-2015-0013. Epub 2015 Sep 30. PMID: 27847895; PMCID: PMC4936458.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries